Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs The Edit

Eden
Graded #32

Higher grade

vs+11.2
The Edit
Graded #113

Lower grade

The verdict

Eden takes it — 81.6/100 to 70.4/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. High-disclosure, high-oversight compounded program with the cleanest verification signals.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEden +35
85
50
Dose & formulationEden +14
86
72
Clinical oversightThe Edit +25
55
80
Labs & monitoringEden +30
92
62
FulfillmentThe Edit +2
93
95
Contract termsEden +5
90
85
Eden · left barThe Edit · right bar

The numbers

MetricEdenThe Edit
WeighScore81.6/10070.4/100
GradeB−C
Scorecard rank#32#113
Semaglutide$239/mo$259/mo (standing rate, flat at every dose; $200 covers the first month only)
Tirzepatide$349/mo$349/mo (standing rate, flat at every dose; $300 covers the first month only)
CoverageAll 50 statesAll 50 states (claimed; hedged in the same paragraph, no list published)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Eden

Graded #32 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • High verification confidence
  • Nationwide
  • Both molecules

Where it loses points

  • Premium pricing
  • Compounded only
The Edit

Graded #113 · C

Strengths

  • The price is flat at every dose with no titration ladder, so the figure a reader sees is the figure at maintenance
  • Nothing is charged and no card is taken to begin, and a full refund applies if a clinician does not approve treatment
  • Names its medical director with an NPI number and the medical practice behind him, and names a dispensing pharmacy
  • Prescription medication, injection supplies, the clinician visit and ongoing care are itemized as included, with no membership fee
  • A separate hormone menu is priced beside the GLP-1 lines

Where it loses points

  • $200 and $300 are first-order promotional prices printed larger than the struck standing rates of $259 and $349, and the promotion carries no end date and no code
  • The published cancellation and refund policies say the Membership Agreement controls where they differ, and that nothing on the public site is binding — so the terms a reader can read are not the terms that apply
  • Two-day shipping is transit time only; the site's own shipping policy states an average of 4 to 12 business days from prescription
  • “Available in all 50 U.S. states” is hedged in the same paragraph and no state list is published anywhere
  • The three- and six-month figures are one charge, not a monthly rate, and the per-month numbers beside them are arithmetic rather than billing
  • The named pharmacy is described as one member of a plural pharmacy network whose other members are not named
  • No compounding class is stated, and whether a separate visit fee is ever charged is not answered

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard